Overview

COMMITTED TO THE DESIGN, DEVELOPMENT, AND DELIVERY OF INNOVATIVE AND CREATIVE EVIDENCE-BASED EDUCATION PROGRAMS


Ask the Experts: Identifying the Needs of Patients with Severe Asthma (Module 1)

This CME-accredited CME Snapshot™ four-part series is intended for primary care providers, including internists, family physicians, nurse practitioners, and physician assistants involved in the ongoing management of patients with severe asthma. The faculty will review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making and multidis...
Integritas Communications

Best Practices in Communicating About Sexual Health: What's Your Style?

Part 1: Video-Based Program - Best Practices in Communicating About Sexual Health: What's Your Style? Compare and contrast patient-clinician interactions What is your patient not telling you? Tools, tips, and conversation-starters to avoid stigma and optimize engagement
Integritas Communications

Biologics for Severe Asthma A Growing Treatment Class: Module 4

This CME-accredited four-part CME Snapshot™ series is intended for pulmonologists, allergists, and other specialists involved in the long-term care of patients with severe asthma. In this educational series, expert faculty will review clinical practice guidelines, discuss new approaches to therapy, and hear directly from patients with severe asthma.
Integritas Communications

Biologics for Severe Asthma: Case-Based Conversations

This CME-accredited four-part CME Snapshot™ series is intended for pulmonologists, allergists, and other specialists involved in the long-term care of patients with severe asthma. In this educational series, expert faculty will review clinical practice guidelines, discuss new approaches to therapy, and hear directly from patients with severe asthma.
Integritas Communications

BLOCK HIV/HCV

Approximately 25% of all individuals infected with HIV are coinfected with HCV.1 Of critical significance, HIV increases the rate of progression of HCV-related hepatic fibrosis, and HCV is associated with a 3-fold increase in HIV antiretroviral therapy-induced liver toxicity.2 Further, these synergistic diseases often occur in adverse socioeconomic conditions that significantly increase the vuln...
Integritas Communications

BRIDGE: HCV

BRIDGE HCV is an exciting grassroots initiative that taps into the strengths and resources of communities in inner-city and metropolitan areas to provide effective treatment for hepatitis C virus (HCV) in people who inject drugs (PWID). Now, drawing upon dynamic content presented at live small-group meetings for community-based health care professionals, this enduring program will bring the crit...
Integritas Communications

Clearing the Air in Severe Asthma Management: Improving Patient Outcomes Through Shared Clinical Decision Making

An outsized proportion of asthma-related morbidity and mortality is borne by the 5% to 15% of affected patients who have severe forms of the disease.1,2 These patients suffer from poorly controlled symptoms and frequent exacerbations, often despite daily treatment with high-dose inhaled corticosteroids and other long-acting controller medications.1,2 Ongoing research has elucidated key pathophys...
Integritas Communications

Clinical Issues in Chronic Pain: Debates and Discussions About Therapeutically Targeting Nerve Growth Factor Signaling

Chronic pain affects 100 million Americans and has significant health and socioeconomic repercussions.1 Appropriate pain management can improve patient quality of life and overall outcomes and also reduce health care costs.1 Although nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids are often prescribed to manage chronic pain, both analgesic classes are associated with risks and are not ...
Integritas Communications

Clinical Issues in Rheumatoid Arthritis: Discussions and Debates on the Evolving Roles of Targeted Synthetic DMARDs

Rheumatoid arthritis (RA) is a chronic inflammatory joint disease that can cause bone and cartilage damage and lead to disability.1 RA affects about 24.5 million people, with 5 and 50 per 100,000 people newly developing the condition each year.1,2 RA has resulted in increased mortality in recent years, creating a need for an understanding of treat-to-target recommendations and appropriate diseas...
Integritas Communications

Clinical Issues in Severe Asthma: Debates and Discussions About Personalizing Patient Management

An outsized proportion of asthma-related morbidity and mortality is borne by the 5% to 15% of affected patients who have severe forms of the disease.1,2 These patients suffer from poorly controlled symptoms and frequent exacerbations, often despite daily treatment with high-dose inhaled corticosteroids and other long-acting controller medications.1,2 Ongoing research has elucidated key pathophys...
Integritas Communications

Clinical Issues™ in Chronic Liver Disease: Hot Topics in HBV, HCV, and NASH

Three chronic diseases of the liver – HCV infection, HBV infection, and NASH – are commonly managed by gastroenterologists and hepatologists. Despite the availability of safe and effective treatments for HCV, many chronically infected patients remain unscreened, undiagnosed, and untreated.1 People who inject drugs (PWID) represent a population in particular need of recognition, diagnosis, an...
Integritas Communications

Clinical Profiles of Current and Emerging GLP-1 RAs (Module 1 of 4)

This CME-accredited CME Snapshot™ four-part series is intended for endocrinologists, primary care providers (PCPs), and other health care providers involved in the identification, evaluation, and treatment of patients with T2DM. During these activities, two expert faculty will participate in a series of interactive discussions on recent evidence related to glucagon-like peptide 1 receptor agon...
Integritas Communications

Collaborating with Patients to Reduce Long-Term Hypercholesterolemia Risks

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and t...
Integritas Communications

Differential Diagnosis Multidisciplinary Management, and Patient Engagement (Module 4)

This CME-accredited CME Snapshot™ four-part series is intended for primary care providers, including internists, family physicians, nurse practitioners, and physician assistants involved in the ongoing management of patients with severe asthma. The faculty will review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making and multidis...
Integritas Communications

Evaluations And Treatment of Virologic Failure: Emerging Concepts

This CME/CE-accredited CME Snapshot™ four-part series is intended for infectious disease physicians and other clinicians who manage patients with HIV. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with HIV.
Integritas Communications

Evolving Management Strategies for Moderate-to-Severe Atopic Dermatitis: Looking Beyond Barriers to Optimize Therapy

Atopic dermatitis is a common, chronic inflammatory disease that manifests primarily in the skin, although research has uncovered potentially deleterious effects in other organ systems throughout the body.1,2 The disease-related physical and biopsychosocial burdens of atopic dermatitis can have a substantial effect on patients’ quality of life, particularly in those with moderate-to-severe dis...
Integritas Communications

Guidelines on Severe Asthma: A Practical Synthesis for Specialists

This CME-accredited four-part CME Snapshot™ series is intended for pulmonologists, allergists, and other specialists involved in the long-term care of patients with severe asthma. In this educational series, expert faculty will review clinical practice guidelines, discuss new approaches to therapy, and hear directly from patients with severe asthma.
Integritas Communications

HCV Updates and Insights: Realities, Challenges, and Opportunities to Improve Care

We, in the correctional community, have a critical part to play in shaping health care delivery and advocating for our patients. This is especially pertinent to HCV care, in which significant gaps in testing, treatment, prevention, and education persist—both behind bars and upon community reentry. Across the corrections-based HCV-care continuum, providers are faced not only with challenges, bu...
Integritas Communications

HIV Experts & Evidence™: Evolving Models of HIV Care (Volume 1) - Rapid ART Initiation: A New Addition to the HIV-Care Tool Box

Best practice recommendations for treatment of patients infected with HIV are continually evolving and now include strategies related to early initiation of antiretroviral therapy (ART).1 The results of pivotal clinical trials have demonstrated not only the benefits of early and continuous ART for long-term health outcomes in people living with HIV,2,3 but also a profound decrease in HIV transmi...
Integritas Communications

HIV Updates and Insights: Realities, Challenges, and Opportunities to Improve Care

We, in the correctional community, have a critical part to play in shaping health care delivery and advocating for our patients. This is especially pertinent to HIV care, in which significant gaps in treatment and prevention persist—both behind bars and upon community reentry. Across the corrections-based HIV-care continuum, from testing to harm-reduction practices to sustained viral suppressi...
Integritas Communications

Identifying Cases of Severe Asthma (Module 2)

This CME-accredited CME Snapshot™ four-part series is intended for primary care providers, including internists, family physicians, nurse practitioners, and physician assistants involved in the ongoing management of patients with severe asthma. The faculty will review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making and multidis...
Integritas Communications

Individualizing LDL-C Targets in High-Risk Patients

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and t...
Integritas Communications

Inhibition of IL-6 Signaling in the Management of Rheumatoid Arthritis

This CME/CE-accredited CME Snapshot™ series of educational videos has been created for rheumatologists and other clinicians involved in treating patients with rheumatoid arthritis (RA). During each 15-minute activity, two expert rheumatologists focus on a specific aspect of long-term RA management, including practical advice on implementing international treat-to-target guidelines as well as t...
Integritas Communications

Initiating Intrathecal Therapy For Patients With Severe Chronic Pain (Module 3)

This CME-accredited CME/CE Snapshot™ four-part series is intended for pain specialists, pain management nurses, and other clinicians who manage patients treated with intrathecally delivered analgesics for chronic pain. The faculty will also review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making.
Integritas Communications

Intrathecal Therapy for Severe Chronic Pain: Evidence-Based Recommendations: Module 1

Chronic pain affects 100 million Americans. Certain patients with chronic pain are candidates for intrathecal (IT) therapy, which can mitigate some of the risks associated with systemic opioids. Following appropriate patient selection based on medical and psychiatric history and a physical exam, a patient can begin a trial with morphine or ziconotide, the 2 US Food and Drug Administration (FDA)...
Integritas Communications

JAK Inhibition in Inflammatory Bowel Disease

This activity has been designed to meet the educational needs of gastroenterologists and rheumatologists who care for patients with inflammatory bowel disease or rheumatoid arthritis.
Integritas Communications

JAK Inhibition in Rheumatoid Arthritis

With increasing evidence showing that the Janus kinase (JAK) inhibition can be used as a target for certain immune-mediated diseases, this activity reviews the benefits and safety concerns gastroenterologists and rheumatologists need to consider.
Integritas Communications

JAK Inhibitors in the Management of Rheumatoid Arthritis

This CME/CE-accredited CME Snapshot™ series of educational videos has been created for rheumatologists and other clinicians involved in treating patients with rheumatoid arthritis (RA). During each 15-minute activity, two expert rheumatologists focus on a specific aspect of long-term RA management, including practical advice on implementing international treat-to-target guidelines as well as t...
Integritas Communications

JAK-STAT Signaling and Disease Pathogenesis in RA and IBD

With increasing evidence showing that the Janus kinase (JAK) inhibition can be used as a target for certain immune-mediated diseases, this activity reviews the benefits and safety concerns gastroenterologists and rheumatologists need to consider.
Integritas Communications

Long-term Cardiovascular Outcomes Trials With PCKS9 Inhibitors

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and t...
Integritas Communications

Long-Term Monitoring Of Patients Treated With Intrathecal Analgesics (Module 4)

This CME-accredited CME/CE Snapshot™ four-part series is intended for pain specialists, pain management nurses, and other clinicians who manage patients treated with intrathecally delivered analgesics for chronic pain. The faculty will also review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making.
Integritas Communications

Looking at the Big Picture of IBD

The burden of inflammatory bowel diseases (IBD), of which Chroh's disease and ulcerative colitis are the primary entities, is significant and wide ranging. IBD that is not well-controlled impairs quality of life, social activities, travel and ability to work, leading to higher rates of absenteeism and permanent work disability.1,2 The idiopathic intestinal inflammation of IBD requires life-long...
Integritas Communications

New Insights Into Rheumatoid Arthritis Pathophysiology: Module 6

This CME-accredited CME Snapshot™ series of educational videos has been created for rheumatologists and other clinicians involved in treating patients with rheumatoid arthritis (RA). During each 15-minute activity, two expert rheumatologists focus on a specific aspect of long-term RA management, including practical advice on implementing international treat-to-target guidelines as well as the ...
Integritas Communications

Novel Nonstatin LDL-C Targets in High-Risk Patients

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and t...
Integritas Communications

Overcoming Barriers to Injectable Noninsulin Therapies (Module 3 of 4)

This CME-accredited CME Snapshot™ four-part series is intended for endocrinologists, primary care providers (PCPs), and other health care providers involved in the identification, evaluation, and treatment of patients with T2DM. During these activities, two expert faculty will participate in a series of interactive discussions on recent evidence related to glucagon-like peptide 1 receptor agon...
Integritas Communications

Overview of Intrathecal Therapy For Chronic Pain (Module 1)

This CME-accredited CME/CE Snapshot™ four-part series is intended for pain specialists, pain management nurses, and other clinicians who manage patients treated with intrathecally delivered analgesics for chronic pain. The faculty will also review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making.
Integritas Communications

Pathways to Better Outcomes in Systemic Lupus Erythematosus: Translating Pathophysiology into Targeted Treatments

SLE is a chronic, autoimmune disorder that can present with a variety of clinical manifestations, commonly including arthritis, fever, photosensitivity, and malar rash.1,2 The disease is pathologically characterized by generalized, multisystem inflammation and the presence of a number of potential autoantibodies and immune complexes.2,3 Scientific and clinical research on SLE has uncovered facto...
Integritas Communications

Patient Engagement Via Open Communication (Module 3)

This CME-accredited CME Snapshot™ four-part series is intended for primary care providers, including internists, family physicians, nurse practitioners, and physician assistants involved in the ongoing management of patients with severe asthma. The faculty will review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making and multidis...
Integritas Communications

Pharmacoeconomic Outcomes of Suboptimal LDL-C Management

This accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their...
Integritas Communications

Pharmacoeconomic Outcomes of Suboptimal LDL-C Management

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and t...
Integritas Communications

Practical Recommendations and Demonstrations: Module 2

Chronic pain affects 100 million Americans. Certain patients with chronic pain are candidates for intrathecal (IT) therapy, which can mitigate some of the risks associated with systemic opioids. Following appropriate patient selection based on medical and psychiatric history and a physical exam, a patient can begin a trial with morphine or ziconotide, the 2 US Food and Drug Administration (FDA)...
Integritas Communications

Practical Recommendations for Noninsulin Injectable Therapies (Module 4 of 4)

This CME-accredited CME Snapshot™ four-part series is intended for endocrinologists, primary care providers (PCPs), and other health care providers involved in the identification, evaluation, and treatment of patients with T2DM. During these activities, two expert faculty will participate in a series of interactive discussions on recent evidence related to glucagon-like peptide 1 receptor agon...
Integritas Communications

PrEP U™: HIV-Prevention Education for University Student Health Centers

PrEP U™: HIV-Prevention Education for University Student Health Centers is a comprehensive professional and lay-leadership training program to help you meet the health needs of your university community. This online enduring activity for professionals from university health centers seeks to help participants understand the changing landscape of HIV in the southeast, particularly among the univ...
Integritas Communications

Preventing HIV Infection With PrEP: Manage This Patient

Part 2: Case-Based Program - Manage This Patient: Preventing HIV Infection With PrEP Assessing HIV risk and PrEP eligibility Pre-PrEP testing and initiation of treatment On-treatment monitoring and adherence/risk-reduction counseling
Integritas Communications

Raising the Bar by Lowering the Target

This CME-accredited CME Snapshot™ highlights program compiles the key takeaways from a seven-part series intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During this activity, expert faculty will participate in a series of inter...
Integritas Communications

Reducing Cardiovascular Risk in Patients with T2DM (Module 2 of 4)

This CME-accredited CME Snapshot™ four-part series is intended for endocrinologists, primary care providers (PCPs), and other health care providers involved in the identification, evaluation, and treatment of patients with T2DM. During these activities, two expert faculty will participate in a series of interactive discussions on recent evidence related to glucagon-like peptide 1 receptor agon...
Integritas Communications

Selecting Patients Who May Benefit From Intrathecal Drug Delivery For Severe Chronic Pain (Module 2)

This CME-accredited CME/CE Snapshot™ four-part series is intended for pain specialists, pain management nurses, and other clinicians who manage patients treated with intrathecally delivered analgesics for chronic pain. The faculty will also review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making.
Integritas Communications

Tailored Lipid-Lowering Regiments for Specific Very High-Risk Profiles

This accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their...
Integritas Communications

Tailored Lipid-Lowering Regiments for Specific Very High-Risk Profiles

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and t...
Integritas Communications

Tailoring Long-Term Maintenance Regimens for Severe Asthma

This CME-accredited four-part CME Snapshot™ series is intended for pulmonologists, allergists, and other specialists involved in the long-term care of patients with severe asthma. In this educational series, expert faculty will review clinical practice guidelines, discuss new approaches to therapy, and hear directly from patients with severe asthma.
Integritas Communications

The Big (& Small) Picture of NASH: Building Your Understanding to Combat a Growing Problem

Nonalcoholic steatohepatitis (NASH), part of the nonalcoholic fatty liver disease (NAFLD) spectrum, is characterized by steatosis, lobular inflammation, hepatocyte ballooning, and varying degrees of fibrosis.1 Both obesity and diabetes play large roles in development and progression of NAFLD and NASH, and the growing prevalence of NAFLD and NASH parallel the rise in obesity and diabetes.2 In add...
Integritas Communications

The Changing Architecture of HIV Care Review of Novel Agents and Approaches

This CME/CE-accredited CME Snapshot™ four-part series is intended for infectious disease physicians and other clinicians who manage patients with HIV. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with HIV.
Integritas Communications

The Changing Landscape of IBD: Emerging Concepts in Patient Management

In the past 2 decades, the introduction of biologic therapies that target underlying disease processes has dramatically changed the treatment of the inflammatory bowel diseases (IBDs), ulcerative colitis and Crohn’s disease. Current biologic therapy with tumor necrosis factor inhibitors and anti-integrins has improved the treatment of IBD flares and maintenance of clinical remission. These age...
Integritas Communications

The Nexus of NASH and T2DM: The Emerging Role of the Diabetologist

NAFLD is a spectrum of potentially progressive liver disorders, ranging from simple hepatic steatosis to such severe forms as NASH, fibrosis, and cirrhosis.1 The prevalence rates of both NAFLD and NASH have been steadily trending upwards for years, mirroring the rapid and well-documented expansions of patient populations with obesity and/or T2DM.2-4 Thus, in the coming decade, burdens associated...
Integritas Communications

Through Your Patient’s Eyes™ - Comprehensive Relief from Cancer Pain: Expanding the Conversation on Opioid-Induced Constipation

Despite a growing number of specific treatment options, many patients with cancer pain still suffer from opioid-induced constipation (OIC).1-3 Open communication among patients, caregivers, and treating clinicians is essential to determine the severity and psychosocial consequences of OIC.1-4 Patients with cancer pain and their proxies, however, are often reluctant to discuss opioid-related gast...
Integritas Communications

Updates in HCV Screening and Treatment: Key Issues Impacting OB/GYN Practice

This educational activity is designed to better prepare OB/GYNs to identify patients who should be screened for HCV based on relevant professional society recommendations, appropriately link patients to care, and manage pregnancies of women who have HCV. Expert faculty will provide practical information on HCV screening, confirmatory testing, patient education, and counseling strategies for use ...
Integritas Communications

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.